Virtual Medicinal Product (VMP) - Co-careldopa 12.5mg/50mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Co-careldopa 12.5mg/50mg tablets | Start Date 04-05-2004 | End Date |
| Previous Name | Previous Name Co-careldopa 12.5/50 tablets | Start Date 10-11-2002 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- N04BA02
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 04090100 | Start Date 04-04-2022 | End Date |
| Previous BNF 04090100 | Start Date 22-02-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 39734711000001105 | 27-05-2021 | |
| 323119000 | 10-11-2002 | 26-05-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Carbidopa monohydrate | Based on Base Substance | Carbidopa | 12.5 mg | |
| Levodopa | Based on Ingredient Substance | 50 mg |
Name
Levodopa
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50.0
Strength and UOM (Dmr)
Name
Carbidopa monohydrate
Basis of strength description
Based on Base Substance
BOSS
Carbidopa
Strength and UOM (Nmr)
12.5
Strength and UOM (Dmr)
Parent Products
-
VTMCo-careldopa
-
VMP(Current) Co-careldopa 12.5mg/50mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 90 tablet | 388 | Part VIIIA Category M |
| 100 tablet |